NASDAQ: ASBPAspire Biopharma Holdings Inc Stock Ownership - Who owns Aspire Biopharma Holdings?
Insider buying vs selling
Have Aspire Biopharma Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Donald G. Fell | Director | 2025-06-05 | 10,500 | $0.39 | $4.10kBuy |
| Donald G. Fell | Director | 2025-06-05 | 10,500 | $0.39 | $4.10kBuy |
| Donald G. Fell | Director | 2025-06-05 | 10,500 | $0.39 | $4.10kBuy |
| Donald G. Fell | Director | 2025-06-04 | 9,500 | $0.39 | $3.71kBuy |
| Donald G. Fell | Director | 2025-06-04 | 9,500 | $0.39 | $3.71kBuy |
| Donald G. Fell | Director | 2025-06-04 | 9,500 | $0.39 | $3.71kBuy |
ASBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ASBP insiders and whales buy or sell their stock.
ASBP Shareholders
What type of owners hold Aspire Biopharma Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Surendra K. Ajjarapu | 8.72% | 4,317,500 | $1.70M | Insider |
| Powerup Sponsor LLC | 5.79% | 2,870,000 | $1.13M | Insider |
| Procyon Advisors LLC | 1.31% | 648,411 | $255.47k | Institution |
| Crewe Advisors LLC | 1.27% | 626,854 | $246.98k | Institution |
| Optivise Advisory Services LLC | 0.47% | 235,106 | $92.63k | Institution |
| Jane Street Group LLC | 0.31% | 152,552 | $60.11k | Institution |
| Vr Advisory Services Ltd | 0.20% | 97,391 | $38.37k | Institution |
| Three Seasons Wealth LLC | 0.15% | 75,000 | $29.55k | Institution |
| Periscope Capital Inc | 0.15% | 75,000 | $29.55k | Institution |
| Valley Wealth Managers Inc | 0.08% | 40,000 | $15.76k | Institution |
ASBP vs Biotech Stocks
Aspire Biopharma Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.